A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma

We compared latanoprost monotherapy therapy with timolol/dorzolamide in patients with primary open-angle glaucoma to evaluate the effects on intraocular pressure (IOP) and occurrence of adverse events. IOP and topical side, effects were evaluated at the begining, first, and third months. Mean IOP was decreased at the third month. The most common side effect was hyperemia (43.6%). We Concluded that latanoprost reduces IOP better than fixed combination and its topical side effects are tolerable.